We propose to pursue observations by the Principal Investigator and each of the two Co-Investigators that relate genetic and expression differences in IFNgamma to gender bias in MS. MS is two to three times as common in women, yet pursues a more benign course in women. Two of the investigators have found that the 12 CA-repeat allele of an intron 1 polymorphism in the IFNgamma gene (IFNG), which is associated with increased expression of IFNgamma, is underrepresented in men relative to women with MS and to controls in ethnically different populations. Other polymorphisms in linkage disequilibrium (LD) reveal similar findings, and a LD study suggests that this gender bias trait maps to the 100 kb surrounding the gene. Another of the Co-Investigators has independently found a gender bias in IFNgamma expression such that peripheral blood mononuclear cells (PBMCs) of patients with MS, particularly women, over-express IFNgamma in response to disease-related and unrelated antigenic stimuli. Our hypothesis is that genetic variants in IFNG explain some or all of this variation.
The Specific Aims of this application are: 1) to extend the genetic observations to all of our populations and to fine map this trait further to the locus; 2) to analyze the functional significance of these genetic variants using appropriate allelic reporter constructs; and 3) to correlate genotype of individuals with phenotype (TH1/TH2) of cells of patients with MS and with the level of IFNgamma expression. The long-term goals of this project are to understand gender bias in susceptibility to MS and to pursue a genetic association in a complex genetic disease (MS) to yield definitive conclusions regarding causality. If successful, this paradigm could be applied to a number of similar genetic association studies.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS045442-02
Application #
6660762
Study Section
Special Emphasis Panel (ZAI1-NN-I (J2))
Program Officer
Utz, Ursula
Project Start
2002-09-30
Project End
2005-08-31
Budget Start
2003-09-01
Budget End
2004-08-31
Support Year
2
Fiscal Year
2003
Total Cost
$262,853
Indirect Cost
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
006471700
City
Rochester
State
MN
Country
United States
Zip Code
55905
Kantarci, Orhun H; Hebrink, David D; Schaefer-Klein, Janet et al. (2008) Interferon gamma allelic variants: sex-biased multiple sclerosis susceptibility and gene expression. Arch Neurol 65:349-57
Suppiah, V; Goris, A; Alloza, I et al. (2005) Polymorphisms in the interleukin-4 and IL-4 receptor genes and multiple sclerosis: a study in Spanish-Basque, Northern Irish and Belgian populations. Int J Immunogenet 32:383-8
Kantarci, O H; Goris, A; Hebrink, D D et al. (2005) IFNG polymorphisms are associated with gender differences in susceptibility to multiple sclerosis. Genes Immun 6:153-61
Suppiah, V; Alloza, I; Heggarty, S et al. (2005) The CTLA4 +49 A/G*G-CT60*G haplotype is associated with susceptibility to multiple sclerosis in Flanders. J Neuroimmunol 164:148-53